CAYLA-InvivoGen is a biotechnology company that develops innovative products for research in biology.
The company is organized in three entities.
CAYLA specializes in the production of active ingredients using fermentation technologies (antibiotics and cosmetics).
InvivoGen offers innovative reagents for research in molecular and cell biology (innate immunity).
InvivoGen Therapeutics develops monoclonal antibodies and DNA medicines for the treatment of cancer (pancreatic cancer Phase I)
The company is organized in three entities.
CAYLA specializes in the production of active ingredients using fermentation technologies (antibiotics and cosmetics).
InvivoGen offers innovative reagents for research in molecular and cell biology (innate immunity).
InvivoGen Therapeutics develops monoclonal antibodies and DNA medicines for the treatment of cancer (pancreatic cancer Phase I)